|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Micke P, Faldum A, Metz T, Beeh KM,
Bittinger F, Hengstler JG and Buhl R: Staging small cell lung
cancer: Veterans Administration Lung Study Group versus
International Association for the Study of Lung Cancer-what limits
limited disease? Lung Cancer Amst Neth. 37:271–276. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang B, Guo H, Xu H, Yu H, Chen Y and Zhao
G: Research progress and challenges in the treatment of central
nervous system metastasis of non-small cell lung cancer. Cells.
10:26202021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chauhan AF and Liu SV: Small cell lung
cancer: Advances in diagnosis and management. Semin Respir Crit
Care Med. 41:435–446. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chu X, Li S, Xia B, Chu L, Yang X, Ni J,
Zou L, Li Y, Xie C, Lin J and Zhu Z: Patterns of brain metastasis
immediately before prophylactic cranial irradiation (PCI):
implications for PCI optimization in limited-stage small cell lung
cancer. Radiat Oncol Lond Engl. 14:1712019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu Q and Chen M, Peng F, Zhang Q, Kong Y,
Bao Y, Xu Y, Hu X and Chen M: A study of the prognosis of patients
with limited-stage small cell lung cancer who did or did not
receive prophylactic cranial irradiation after effective
chemoradiotherapy. Front Oncol. 13:11183712023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tai P, Assouline A, Joseph K, Stitt L and
Yu E: Prophylactic cranial irradiation for patients with
limited-stage small-cell lung cancer with response to
chemoradiation. Clin Lung Cancer. 14:40–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aupérin A, Arriagada R, Pignon JP, Le
Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka
H, Wagner H and Aisner J: Prophylactic cranial irradiation for
patients with small-cell lung cancer in complete remission.
Prophylactic Cranial Irradiation Overview Collaborative Group. N
Engl J Med. 341:476–484. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chun SG, Simone CB II, Amini A, Chetty IJ,
Donington J, Edelman MJ, Higgins KA, Kestin LL, Movsas B, Rodrigues
GB, et al: American Radium Society Appropriate Use Criteria:
Radiation Therapy for Limited-Stage SCLC 2020. J Thorac Oncol.
16:66–75. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Couñago F, de la Pinta C, Gonzalo S,
Fernández C, Almendros P, Calvo P, Taboada B, Gómez-Caamaño A,
Guerra JLL, Chust M, et al: GOECP/SEOR radiotherapy guidelines for
small-cell lung cancer. World J Clin Oncol. 12:115–143. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moreno AC and Lin SH: The optimal
treatment approaches for stage I small cell lung cancer. Transl
Lung Cancer Res. 8:88–96. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu C, Li M, Cai X, Yuan S, Cao J, Zhu S,
Chen M, Bi N, Hu X, Li J, et al: Practice patterns of treatment
strategy of limited-stage small-cell lung cancer: Survey of Chinese
Oncologists. Front Oncol. 12:8723242022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan M, Zhao Y, Arkenau HT, Lao T, Chu L
and Xu Q: Signal pathways and precision therapy of small-cell lung
cancer. Signal Transduct Target Ther. 7:1872022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Patel SR and Das M: Small cell lung
cancer: Emerging targets and strategies for precision therapy.
Cancers (Basel). 15:40162023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rami-Porta R, Asamura H, Travis WD and
Rusch VW: Lung cancer-major changes in the American Joint Committee
on Cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:138–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Wang Y, Ren F, Huang Z, Tan B,
Zhao Z, Yu X, Dong P, Yu J and Meng X: Prophylactic cranial
irradiation (PCI) versus active surveillance in patients with
limited-stage small cell lung cancer: A retrospective, multicentre
study. Respir Res. 23:2742022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gondi V, Deshmukh S, Brown PD, Wefel JS,
Armstrong TS, Tome WA, Gilbert MR, Konski A, Robinson CG, Bovi JA,
et al: Sustained preservation of cognition and prevention of
patient-reported symptoms with hippocampal avoidance during
whole-brain radiation therapy for brain metastases: Final results
of NRG oncology CC001. Int J Radiat Oncol Biol Phys. 117:571–580.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gondi V, Tome WA, Marsh J, Struck A, Ghia
A, Turian JV, Bentzen SM, Kuo JS, Khuntia D and Mehta MP: Estimated
risk of perihippocampal disease progression after hippocampal
avoidance during whole-brain radiotherapy: Safety profile for RTOG
0933. Radiother Oncol. 95:327–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gondi V, Pugh SL, Tome WA, Caine C, Corn
B, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, et
al: Preservation of memory with conformal avoidance of the
hippocampal neural stem-cell compartment during whole-brain
radiotherapy for brain metastases (RTOG 0933): A phase II
multi-institutional trial. J Clin Oncol. 32:3810–3816. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bogart JA, Waqar SN and Mix MD: Radiation
and systemic therapy for limited-stage small-cell lung cancer. J
Clin Oncol. 40:661–670. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan L, Fan X, Wang L, Wang Y, Li Y, Cui Y,
Zheng H, Yi Q and Wu K: Prophylactic cranial irradiation for
limited-stage small-cell lung cancer in the magnetic resonance
imaging era. Cancer Med. 12:2484–2492. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Held MK, Hansen O, Schytte T, Hansen KH,
Bahij R, Nielsen M, Nielsen TB and Jeppesen SS: Outcomes of
prophylactic cranial irradiation in patients with small cell lung
cancer in the modern era of baseline magnetic resonance imaging of
the brain. Acta Oncol. 61:185–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pezzi TA, Fang P, Gjyshi O, Feng L, Liu S,
Komaki R and Lin SH: Rates of overall survival and intracranial
control in the magnetic resonance imaging era for patients with
limited-stage small cell lung cancer with and without prophylactic
cranial irradiation. JAMA Netw Open. 3:e2019292020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lim YJ, Song C and Kim HJ; Korean
Association for Lung Cancer, Korea Central Cancer Registry, :
Survival impact of prophylactic cranial irradiation in small-cell
lung cancer in the modern era of magnetic resonance imaging
staging. Radiat Oncol. 17:262022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levy A, Le Péchoux C, Mistry H,
Martel-Lafay I, Bezjak A, Lerouge D, Padovani L, Taylor P and
Faivre-Finn C: Prophylactic cranial irradiation for limited-stage
small-cell lung cancer patients: Secondary findings from the
prospective Randomized phase 3 CONVERT trial. J Thorac Oncol.
14:294–297. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen MY, Ji Y, Hu X and Chen M: Factors
affecting the risk of brain metastasis in limited-stage small cell
lung cancer after prophylactic cranial irradiation. Cancer Manag
Res. 14:1807–1814. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Ma K, Yang Z, Cui J, He H, Hoffman
AR, Hu JF and Li W: Systematic correlation analyses of circulating
tumor cells with clinical variables and tumor markers in lung
cancer patients. J Cancer. 8:3099–3104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cen M, Jin J, Ji Y, Hu X and Chen M: Risk
assessment of brain metastases after prophylactic brain irradiation
in 550 patients with limited-stage small cell lung cancer who
achieved remission through chemoradiotherapy. Chin J Radiat Oncol.
31:138–142. 2022.
|
|
30
|
Kim TG, Pyo H, Ahn YC, Noh JM and Oh D:
Role of prophylactic cranial irradiation for elderly patients with
limited-disease small-cell lung cancer: Inverse probability of
treatment weighting using propensity score. J Radiat Res.
60:630–638. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farooqi AS, Holliday EB, Allen PK, Wei X,
Cox JD and Komaki R: Prophylactic cranial irradiation after
definitive chemoradiotherapy for limited-stage small cell lung
cancer: Do all patients benefit? Radiother Oncol. 122:307–312.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wolfson AH, Bae K, Komaki R, Meyers C,
Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI and
Choy H: Primary analysis of a phase II randomized trial Radiation
Therapy Oncology Group (RTOG) 0212: Impact of different total doses
and schedules of prophylactic cranial irradiation on chronic
neurotoxicity and quality of life for patients with limited-disease
small-cell lung cancer. Int J Radiat Oncol Biol Phys. 81:77–84.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Slotman B, Faivre-Finn C, Kramer G, Rankin
E, Snee M, Hatton M, Postmus P, Collette L, Musat E and Senan S;
EORTC Radiation Oncology Group and Lung Cancer Group, :
Prophylactic cranial irradiation in extensive small-cell lung
cancer. N Engl J Med. 357:664–672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takahashi T, Yamanaka T, Seto T, Harada H,
Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, et
al: Prophylactic cranial irradiation versus observation in patients
with extensive-disease small-cell lung cancer: A multicentre,
randomised, open-label, phase 3 trial. Lancet Oncol. 18:663–671.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi M, Lee Y, Moon SH, Han JY, Kim HT and
Lee JS: Effect of accurate staging using positron emission
tomography on the outcomes of prophylactic cranial irradiation in
patients with limited stage small-cell lung cancer. Clin Lung
Cancer. 18:77–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng H, Hendriks LEL, van Geffen WH,
Witlox WJA, Eekers DBP and De Ruysscher DKM: Risk factors for
neurocognitive decline in lung cancer patients treated with
prophylactic cranial irradiation: A systematic review. Cancer Treat
Rev. 88:1020252020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mehta MP: Models support prophylactic
cranial irradiation. J Clin Oncol. 24:3524–3526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Witlox WJA, Ramaekers BLT, Lacas B, Le
Pechoux C, Pignon JP, Sun A, Wang SY, Hu C, Redman M, van der Noort
V, et al: Individual patient data meta-analysis of prophylactic
cranial irradiation in locally advanced non-small cell lung cancer.
Radiother Oncol. 158:40–47. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Taylor JM, Rusthoven CG and Moghanaki D:
Prophylactic cranial irradiation or MRI surveillance for extensive
stage small cell lung cancer. J Thorac Dis. 12:6225–6233. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zeng H, De Ruysscher DKM, Hu X, Zheng D,
Yang L, Ricardi U, Kong FMS and Hendriks LEL: Radiotherapy for
small cell lung cancer in current clinical practice guidelines. J
Natl Cancer Cent. 2:113–125. 2022. View Article : Google Scholar
|
|
41
|
Takada M, Fukuoka M, Kawahara M, Sugiura
T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T,
et al: Phase III study of concurrent versus sequential thoracic
radiotherapy in combination with cisplatin and etoposide for
limited-stage small-cell lung cancer: Results of the Japan Clinical
Oncology Group Study 9104. J Clin Oncol. 20:3054–3060. 2002.
View Article : Google Scholar : PubMed/NCBI
|
